QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Terman, G. W. Articles by Chavkin, C. Search for Related Content PubMed PubMed Citation Articles by Terman, G. W. Articles by Chavkin, C.

 Previous Article  |  Next Article 

The Journal of Neuroscience, June 15, 2000, 20(12):4379-4388

Opioid Modulation of Recurrent Excitation in the Hippocampal Dentate Gyrus

Gregory W. Terman^{1, 3}, Carrie T. Drake⁴, Michele L. Simmons², Teresa A. Milner⁴, and Charles Chavkin^{2, 3}

Departments of ¹ Anesthesiology and ² Pharmacology and ³ the Graduate Program in Neurobiology and Behavior, University of Washington School of Medicine, Seattle, Washington 98195-6540, and ⁴ Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York 10021

opioid receptor activation inhibits granule cell-mediated excitatory neurotransmission in the hippocampal formation via a decrease in glutamate release from both perforant path and mossy fiber terminals. We now report a third, anatomically and pharmacologically distinct site of such  opioid inhibition within the hippocampus. Granule cell population responses to selective stimulation of an excitatory hilar pathway were decreased by the ₁ opioid receptor agonist U69,593, an effect blocked by the ₁ antagonist norbinaltorphimine. U69,593 also inhibited hilar path induced long-term potentiation (LTP) of granule cell responses. LTP in this pathway was also blocked by the NMDA receptor antagonist D-2-amino-5-phosphonovalerate, unlike granule cell mossy fiber LTP in CA3.

The  opioid peptide dynorphin is present in hilar mossy fiber collaterals. Ultrastructural analysis of these collaterals demonstrated dynorphin-containing vesicles in asymmetric synapses formed between axon terminals and granule cell dendrites, suggesting direct granule cell-granule cell connections. Evoked release of endogenous dynorphin within the hilus was effective in reducing hilar excitation of granule cells, although this release, in contrast to the release of dynorphin in the dentate molecular layer, was not dependent on L-type calcium channels.

No hilar path excitation was observed in the absence of bicuculline, suggesting a strong GABA_A-mediated inhibition of this pathway. However, hilar path activity could be seen after LTP, with or without bicuculline. Thus,  opioids can inhibit granule cell recurrent excitation, likely via effects on excitatory mossy fiber collaterals. Such collaterals are thought to be important in mediating temporal lobe epilepsy.

Key words: hippocampus; dentate gyrus; opioids; endogenous opioids; dynorphin; long-term potentiation; mossy fibers; hilus; granule cell; guinea pig

---

Copyright © 2000 Society for Neuroscience  0270-6474/00/20124379-10$05.00/0

This article has been cited by other articles:

				S. Loacker, M. Sayyah, W. Wittmann, H. Herzog, and C. Schwarzer Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors Brain, April 1, 2007; 130(4): 1017 - 1028. [Abstract] [Full Text] [PDF]

				B. Liu, L. Qin, S.-N. Yang, B. C. Wilson, Y. Liu, and J.-S. Hong Femtomolar Concentrations of Dynorphins Protect Rat Mesencephalic Dopaminergic Neurons against Inflammatory Damage J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1133 - 1141. [Abstract] [Full Text] [PDF]

				T. S. SHIPPENBERG, V. I. CHEFER, A. ZAPATA, and C. A. HEIDBREDER Modulation of the Behavioral and Neurochemical Effects of Psychostimulants by {kappa}-Opioid Receptor Systems Ann. N.Y. Acad. Sci., June 1, 2001; 937(1): 50 - 73. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help